You could try HLA-DR with CD3 and CD16/56 and CD45. The bright DR+ lymphocytes (exclude monocytes) that do not express CD3 or CD16/56 are B lymphocytes. At 9:40 AM -0400 5/24/02, Paula Fukushima wrote: >Hi List, > Does anyone have an idea of B cell antibodies to use to follow disease >in B cell lymphomas >with patients now being given anti-CD22(Epratuzumab) and >anti-CD20(Rituxamab) besides CD19? > > Thanks, Paula > > >Paula Imus >Flow Cytometry >LP, NCI, NIH >10 Center Drive MSC-1500 >Bethesda, Md. 20892-1500 -- ******************************************************************************###################################################################******************************************************************************- Dr. Maurice (Mo) R.G. O'Gorman Associate Professor Pediatrics Northwestern University Medical School Director Diagnostic Immunology and Flow Cytometry Laboratories 2300 Children's Plaza, Chicago, IL 60614 Office Ph. 773 880 3070 Lab Ph. 773 880 4361 Fax 773 880 3739 e-mail: mogorman@northwestern.edu
This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:26:11 EST